NeoPharm CO., LTD. (KOSDAQ:092730)

NeoPharm CO., LTD. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	294,368	180,766	202,163	150,156	193,952	223,279
Market Cap Growth	6.88%	-10.58%	34.63%	-22.58%	-13.13%	-40.95%
Enterprise Value	160,112	66,098	78,166	45,545	97,728	138,586
Last Close Price	18820.00	11850.00	12294.00	8865.37	11049.30	12369.51
PE Ratio	12.22	7.84	8.71	8.82	10.95	12.32
Forward PE	-	8.05	8.05	8.05	10.43	12.07
PS Ratio	2.40	1.52	2.08	1.77	2.21	2.74
PB Ratio	1.69	1.02	1.26	1.06	1.49	1.90
P/TBV Ratio	1.71	1.03	1.28	1.07	1.51	1.94
P/FCF Ratio	12.59	11.42	59.27	8.48	9.08	13.30
P/OCF Ratio	11.73	9.70	8.69	8.27	8.95	13.08
PEG Ratio	-	1.25	1.25	1.25	1.25	1.25
EV/Sales Ratio	1.31	0.56	0.81	0.54	1.11	1.70
EV/EBITDA Ratio	5.55	2.38	2.90	1.98	4.08	5.92
EV/EBIT Ratio	6.24	2.68	3.09	2.12	4.36	6.33
EV/FCF Ratio	6.85	4.18	22.92	2.57	4.58	8.26
Debt / Equity Ratio	0.00	0.00	0.01	0.00	0.00	0.04
Debt / EBITDA Ratio	0.02	0.02	0.04	0.02	0.02	0.18
Debt / FCF Ratio	0.02	0.04	0.31	0.02	0.03	0.26
Asset Turnover	0.64	0.64	0.58	0.57	0.64	0.64
Inventory Turnover	3.42	3.93	3.35	3.19	3.18	3.30
Quick Ratio	5.73	9.21	7.22	9.22	8.74	7.06
Current Ratio	6.27	10.12	7.94	9.99	9.39	7.63
Return on Equity (ROE)	14.39%	13.69%	15.36%	12.50%	14.28%	16.23%
Return on Assets (ROA)	8.34%	8.33%	9.50%	8.97%	10.14%	10.71%
Return on Capital (ROIC)	9.53%	9.10%	10.42%	9.80%	11.09%	11.78%
Return on Capital Employed (ROCE)	14.60%	13.90%	15.80%	15.10%	17.20%	18.50%
Earnings Yield	8.18%	12.76%	11.48%	11.34%	9.13%	8.12%
FCF Yield	7.94%	8.76%	1.69%	11.79%	11.01%	7.52%
Dividend Yield	3.18%	5.06%	3.05%	3.95%	3.17%	2.63%
Payout Ratio	24.35%	25.43%	23.58%	32.15%	28.70%	32.35%
Buyback Yield / Dilution	-	-	-	-	0.95%	-4.38%
Total Shareholder Return	3.32%	5.06%	3.05%	3.95%	4.11%	-1.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.